[Efficacy of levofloxacin 500 mg for middle ear diseases].

Takashi Kimitsuki, Takamasa Yoshida, Shizuo Komune

Research output: Contribution to journalArticle

Abstract

We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.

Original languageEnglish
Pages (from-to)43-48
Number of pages6
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume103
Issue number2
Publication statusPublished - Feb 2012

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of '[Efficacy of levofloxacin 500 mg for middle ear diseases].'. Together they form a unique fingerprint.

  • Cite this

    Kimitsuki, T., Yoshida, T., & Komune, S. (2012). [Efficacy of levofloxacin 500 mg for middle ear diseases]. Fukuoka igaku zasshi = Hukuoka acta medica, 103(2), 43-48.